PNC Financial Services Group
NAGE

PNC Financial Services Group’s Niagen Bioscience NAGE Stock Holding History

PNC Financial Services Group’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7K Buy
1,161
+850
+273% +$3.45K ﹤0.01% 4496
2026
Q1 		$1.37K Sell
311
-143
-31% -$772 ﹤0.01% 4683
2025
Q4 		$2.89K Buy
454
+242
+114% +$1.68K ﹤0.01% 4433
2025
Q3 		$1.98K Buy
212
+12
+6% +$121 ﹤0.01% 4502
2025
Q2 		$2.88K Buy
+200
New +$1.98K ﹤0.01% 4305
2018
Q3 		– Sell
-13,000
Closed -$48K – 4261
2018
Q2 		$48K Buy
+13,000
New +$49.4K ﹤0.01% 3003

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PNC Financial Services Group's NAGE Position: Q2 2026 in Review

PNC Financial Services Group increased its Niagen Bioscience (NAGE) stake by 273% in Q2 2026, buying an estimated $3.45K and bringing the position to 1,161 shares worth $3.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4496.

PNC Financial Services Group first reported a position in NAGE in Q2 2018 and has held it in 6 quarters since. The position peaked at $48K in Q2 2018. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • PNC Financial Services Group held 1,161 shares of Niagen Bioscience worth $3.7K as of Q2 2026.
  • PNC Financial Services Group bought 850 Niagen Bioscience shares in Q2 2026, an estimated $3.45K.
  • Niagen Bioscience made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4496 holding.
  • PNC Financial Services Group first reported a position in Niagen Bioscience in Q2 2018 and has held it in 6 quarters since.
  • PNC Financial Services Group's Niagen Bioscience position peaked at $48K in Q2 2018.
  • 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.